The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director

HONG KONG: HONG KONG, Aug. 11, 2021 /PRNewswire/ -- Insilico Medicine, a global leader in end-to-end AI-powered drug discovery, today announced the appointment of Steven Galson, MD, MPH as the independent member of the board of directors. "Successful drug development depends on speed and increasing the rates of success. AI...

Click to view original post